MCHPP vs QCOM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
QCOM Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
As of Nov 16, 2026, Qualcomm Inc (QCOM) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). MCHPP carries a Unified Composite Score of 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin), whereas QCOM carries 45.8/100 (HOLD) at $171.50 (17.0x Forward P/E, 20.8% operating margin).
- Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. QCOM 45.8/100 HOLD), QCOM captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (20.8% vs. 21.6% operating margin) and revenue trajectory (-8.4% vs. +42.2% YoY).
- Technical & Structure Timing Caution: MCHPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3); meanwhile QCOM is in a Breakdown options structure phase (RSI 47.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About MCHPP vs QCOM6-Pillar Scorecard Institutional Category Breakdown (MCHPP 2 – 4 QCOM)
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: MCHPP (3) vs QCOM (7)| Institutional Metric | MCHPP | QCOM | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | N/A | $189.5B | QCOM | |
| Trailing P/E Ratio | N/M | 13.9x | QCOM | |
| Forward P/E Ratio | N/M | 17.0x | QCOM | |
| Revenue Growth (YoY) | +42.2% | -8.4% | MCHPP | |
| Operating Margin (TTM) | 21.6% | 20.8% | MCHPP | |
| Net Profit Margin | 15.0% | 31.6% | QCOM | |
| Return on Equity (ROE) | 12.6% | 52.8% | QCOM | |
| 52-Week Range Position | 14% ($47–$88) | 36% ($122–$260) | QCOM | |
| Beta / 30D Volatility | 2.16β · 65% Vol | 2.24β · 65% Vol | QCOM | |
| Unified Institutional Score | 57.1 / 100 (HOLD) | 45.8 / 100 (HOLD) | MCHPP | |
| Trailing 12M Revenue (USD) | $5.60B | $43.1B | Scale | |
| Gross Profit Margin (TTM) | 62.7% | 53.1% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · N/M EV/Rev | 1.04x PEG · 4.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $1.87B EBITDA ($12.20 Book/Sh · 12.6% ROE) | $8.65B ($10.5B Net Debt (0.50x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCHPP vs QCOM. Trailing 12-month operating profitability (MCHPP 21.6% vs QCOM 20.8%) and valuation multiples (MCHPP N/M vs QCOM 17.0x Forward P/E) are benchmarked directly in Pillar 4 below.